The American Medical Association (AMA) has tentatively approved an artificial intelligence platform designed to create treatment plans for patients with prostate cancer. The Unfold artificial intelligence platform from US-based Avenda Health, which creates a cancer probability map based on patient-specific data from prostate biopsies and imaging. It has been given a category III Current Procedural […]
